SCHEMBL2063554

SCHEMBL2063554

COc1cccc(-c2cn3cc(-c4cccc(F)c4CO)ccc3n2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 8/20 0.65
NR4A2 P43354 3/20 0.52
KDM4E B2RXH2 4/20 0.46
NPC1 O15118 4/20 0.46
ALDH1A1 P00352 4/20 0.46
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 2/20 0.46
EGLN1 Q9GZT9 1/20 0.45
FYN P06241 2/20 0.45
HPGD P15428 3/20 0.44
THRB P10828 1/20 0.44
LRRK2 Q5S007 1/20 0.44
CYP2C9 P11712 1/20 0.43
KCNH2 Q12809 1/20 0.43
PKM P14618 1/20 0.42
NFKB1 P19838 1/20 0.42
STAT3 P40763 1/20 0.42
STAT1 P42224 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2063042 0.91 ALDH1A3 (0.58) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL2064759 0.86 NR4A2 (0.67) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL2064109 0.85 NR4A2 (0.60) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL2064448 0.85 NR4A2 (0.60) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL2065198 0.85 NR4A2 (0.63) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL2063617 0.84 NR4A2 (0.54) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL3432775 0.84 NR4A2 (0.58) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL2064088 0.84 NR4A2 (0.61) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL3431948 0.83 NR4A2 (0.51) ALDH1A3NR4A2KDM4ENPC1ALDH1A1
SCHEMBL2063098 0.82 NR4A2 (0.63) ALDH1A3NR4A2KDM4ENPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 EP claimed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 US claimed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US claimed
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 EP disclosed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 US disclosed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN ALDH1A3 1255/4885NR4A2 1531/4885KDM4E 1483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.